197 related articles for article (PubMed ID: 32685584)
1. Evaluation of Vaso-occlusive Crises in United States Sickle Cell Disease Patients: A Retrospective Claims-based Study.
Shah N; Bhor M; Xie L; Halloway R; Arcona S; Paulose J; Yuce H
J Health Econ Outcomes Res; 2019; 6(3):106-117. PubMed ID: 32685584
[TBL] [Abstract][Full Text] [Related]
2. Association Between Vaso-Occlusive Crises and Opioid Prescriptions Among Patients with Sickle Cell Disease: A Retrospective Claims-Based Study.
Kang HA; Barner JC; Richards KM; Bhor M; Paulose J; Kutlar A
J Health Econ Outcomes Res; 2020; 7(1):94-101. PubMed ID: 36873574
[No Abstract] [Full Text] [Related]
3. Association between Vaso-occlusive Crises and Opioid Prescriptions among Patients with Sickle Cell Disease: A Retrospective Claims-based Study.
Kang HA; Barner JC; Richards KM; Bhor M; Paulose J; Kutlar A
J Health Econ Outcomes Res; 2020; 7(1):94-101. PubMed ID: 32685602
[TBL] [Abstract][Full Text] [Related]
4. Economic and Clinical Burden of Managing Sickle Cell Disease with Recurrent Vaso-Occlusive Crises in the United States.
Udeze C; Evans KA; Yang Y; Lillehaugen T; Manjelievskaia J; Mujumdar U; Li N; Andemariam B
Adv Ther; 2023 Aug; 40(8):3543-3558. PubMed ID: 37332020
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological interventions for painful sickle cell vaso-occlusive crises in adults.
Cooper TE; Hambleton IR; Ballas SK; Johnston BA; Wiffen PJ
Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31742673
[TBL] [Abstract][Full Text] [Related]
6. Vaso-occlusive crises and costs of sickle cell disease in patients with commercial, Medicaid, and Medicare insurance - the perspective of private and public payers.
Shah NR; Bhor M; Latremouille-Viau D; Kumar Sharma V; Puckrein GA; Gagnon-Sanschagrin P; Khare A; Kumar Singh M; Serra E; Davidson M; Xu L; Guerin A
J Med Econ; 2020 Nov; 23(11):1345-1355. PubMed ID: 32815766
[TBL] [Abstract][Full Text] [Related]
7. Sickle cell disease complications: Prevalence and resource utilization.
Shah N; Bhor M; Xie L; Paulose J; Yuce H
PLoS One; 2019; 14(7):e0214355. PubMed ID: 31276525
[TBL] [Abstract][Full Text] [Related]
8. The relationship between frequency and severity of vaso-occlusive crises and health-related quality of life and work productivity in adults with sickle cell disease.
Rizio AA; Bhor M; Lin X; McCausland KL; White MK; Paulose J; Nandal S; Halloway RI; Bronté-Hall L
Qual Life Res; 2020 Jun; 29(6):1533-1547. PubMed ID: 31933113
[TBL] [Abstract][Full Text] [Related]
9. Medical Resource Use and Costs of Treating Sickle Cell-related Vaso-occlusive Crisis Episodes: A Retrospective Claims Study.
Shah N; Bhor M; Xie L; Paulose J; Yuce H
J Health Econ Outcomes Res; 2020; 7(1):52-60. PubMed ID: 32685598
[TBL] [Abstract][Full Text] [Related]
10. Impact of Hydroxyurea Therapy in Reducing Pain Crises, Hospital Admissions, and Length of Stay Among Sickle Cell Patients in the Eastern Region of Saudi Arabia.
Albohassan H; Ammen M; Alomran AA; Bu Shehab H; Al Sakkak H; Al Bohassan A
Cureus; 2022 Nov; 14(11):e31527. PubMed ID: 36540486
[TBL] [Abstract][Full Text] [Related]
11. A systematic literature review of frequency of vaso-occlusive crises in sickle cell disease.
Zaidi AU; Glaros AK; Lee S; Wang T; Bhojwani R; Morris E; Donohue B; Paulose J; Iorga ŞR; Nellesen D
Orphanet J Rare Dis; 2021 Nov; 16(1):460. PubMed ID: 34727959
[TBL] [Abstract][Full Text] [Related]
12. High Healthcare Utilization in Adolescents with Sickle Cell Disease Prior to Transition to Adult Care: A Retrospective Study.
Kanter J; Bhor M; Li X; Li FY; Paulose J
J Health Econ Outcomes Res; 2019; 6(3):174-184. PubMed ID: 32685589
[TBL] [Abstract][Full Text] [Related]
13. Impact of hospitalized vaso-occlusive crises in the previous calendar year on mortality and complications in adults with sickle cell disease: a French population-based study.
Arlet JB; Herquelot E; Lamarsalle L; Raguideau F; Bartolucci P
Lancet Reg Health Eur; 2024 May; 40():100901. PubMed ID: 38596356
[TBL] [Abstract][Full Text] [Related]
14. Types of crises in sickle cell disease patients presenting at the haematology day care unit (HDCU), University College Hospital (UCH), Ibadan.
Olabode JO; Shokunbi WA
West Afr J Med; 2006; 25(4):284-8. PubMed ID: 17402517
[TBL] [Abstract][Full Text] [Related]
15. Neuropathic Pain in Children with Sickle Cell Disease: The Hidden Side of the Vaso-Occlusive Crisis.
Sigalla J; Duparc Alegria N; Le Roux E; Toumazi A; Thiollier AF; Holvoet L; Benkerrou M; Dugue S; Koehl B
Children (Basel); 2021 Jan; 8(2):. PubMed ID: 33530318
[TBL] [Abstract][Full Text] [Related]
16. Ticagrelor vs placebo for the reduction of vaso-occlusive crises in pediatric sickle cell disease: the HESTIA3 study.
Heeney MM; Abboud MR; Githanga J; Inusa BPD; Kanter J; Michelson AD; Nduba V; Musiime V; Apte M; Inati A; Taksande AM; Andersson M; Åstrand M; Maklad N; Niazi M; Himmelmann A; Berggren AR
Blood; 2022 Sep; 140(13):1470-1481. PubMed ID: 35849650
[TBL] [Abstract][Full Text] [Related]
17. Contemporary Management and Prevention of Vaso-Occlusive Crises (VOCs) in Adults With Sickle Cell Disease.
Weaver SB; Rungkitwattanakul D; Singh D
J Pharm Pract; 2023 Feb; 36(1):139-148. PubMed ID: 34151636
[TBL] [Abstract][Full Text] [Related]
18. Ticagrelor versus placebo for the reduction of vaso-occlusive crises in pediatric sickle cell disease: Rationale and design of a randomized, double-blind, parallel-group, multicenter phase 3 study (HESTIA3).
Heeney MM; Abboud MR; Amilon C; Andersson M; Githanga J; Inusa B; Kanter J; Leonsson-Zachrisson M; Michelson AD; Berggren AR;
Contemp Clin Trials; 2019 Oct; 85():105835. PubMed ID: 31446143
[TBL] [Abstract][Full Text] [Related]
19. Score Predicting Acute Chest Syndrome During Vaso-occlusive Crises in Adult Sickle-cell Disease Patients.
Bartolucci P; Habibi A; Khellaf M; Roudot-Thoraval F; Melica G; Lascaux AS; Moutereau S; Loric S; Wagner-Ballon O; Berkenou J; Santin A; Michel M; Renaud B; Lévy Y; Galactéros F; Godeau B
EBioMedicine; 2016 Aug; 10():305-11. PubMed ID: 27412264
[TBL] [Abstract][Full Text] [Related]
20. Magnetic Resonance Imaging Assessment of Kidney Oxygenation and Perfusion During Sickle Cell Vaso-occlusive Crises.
Deux JF; Audard V; Brugières P; Habibi A; Manea EM; Guillaud-Danis C; Godeau B; Galactéros F; Stehlé T; Lang P; Grimbert P; Audureau E; Rahmouni A; Bartolucci P
Am J Kidney Dis; 2017 Jan; 69(1):51-59. PubMed ID: 27663041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]